Other Transaction Agreement FA86492099073
Award Date
6/4/20
Potential Completion Date
11/3/21
Potential Value
$285K
Federal Agency
Air Force Research Laboratory
Awardee
Genecapture, Inc.
Ultimate Awardee
Not listed
NAICS Category
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Department of the Army Medical Command to Genecapture, Inc., a for-profit startup company, under the Small Business Innovation Research (SBIR) program. The contract, valued at $249,959.25, is for Phase I feasibility research on Genecapture's CAPTURE technology, which enables rapid identification of genetic signatures of pathogens for infectious disease detection and diagnosis. The award has a total small business set-aside designation. Genecapture...
The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a for-profit startup company. The $150,523.52 firm-fixed-price contract is for the development of infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications. Genecapture specializes in rapid pathogen detection solutions using their patented CAPTURE technology. This contract supports DTRA's efforts...
This is a $1,271,417.59 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a small business contractor. The contract is for a Small Business Technology Transfer (STTR) Phase II research project to develop rapid infectious disease detection solutions using Genecapture's patented CAPTURE technology. The work aims to advance fieldable diagnostic platforms for rapidly identifying and testing antibiotic susceptibility of pathogens,...
Genecapture, Inc. was awarded a definitive contract valued at $1,099,956.91 by the Department of the Army Medical Command to conduct research and development under the Small Business Innovation Research (SBIR) Program Phase II. The contract supports Proposal No. H2-0647 titled "Genecapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens." Research will be conducted in Huntsville, Alabama over a period of performance from September 2021 through January 2024 under...
The Defense Threat Reduction Agency (DTRA) awarded a $4,541,420.24 Cost Plus Fixed Fee contract to Genecapture, Inc., a for-profit startup company, to develop infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications under the Small Business Technology Transfer (STTR) program. This Phase III STTR contract supports the company's efforts to advance their patented CAPTURE technology, which rapidly identifies genetic signatures of...
Genecapture, Inc. was awarded a $999,752.38 definitive cost-plus-fixed-fee contract by the Defense Threat Reduction Agency to continue research and development efforts initiated under Phase I of the Small Business Innovation Research program. The contract will support the company's work to deliver infectious disease diagnostics and differentiate between viral and bacterial infections for point-of-care applications, advancing the agency's goals of protecting the United States from weapons of mass...
The Department of the Air Force Materiel Command Research Laboratory awarded a $749,991 firm fixed price purchase order to Definitive Biotechnologies, LLC as part of the Small Business Innovation Research Program Phase II Action. Under this contract, Definitive Biotechnologies will deliver a disposable, multiplex molecular device for simultaneous point-of-care diagnosis of coronavirus disease 2019 and influenza. The contract has a total small business set aside designation. Performance will...
This is a firm-fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Charlot Biosciences Inc., a minority-owned, self-certified small disadvantaged business. The $49,869 contract is for the SBIR (Small Business Innovation Research) Program Phase I development of a system for rapid pathogen threat detection in aerial and field environments. The award is set aside for small businesses. Charlot Biosciences Inc. has received multiple SBIR awards from the Department of the...
<p>The U.S. Air Force Research Laboratory (AFRL) awarded a Small Business Innovation Research (SBIR) Phase II contract worth $1,249,994.00 to Dxlab Inc., a for-profit organization, for the development of a portable and rugged infection diagnostic platform that provides rapid, clinically actionable pathogen detection at deployed locations and military treatment facilities. The contract has a total small business set-aside designation and is set to be completed by December 8, 2025.</p>